{
  "abstract": "Patients in the US are to have easier initial access to a new drug to treat Alzheimer’s disease thanks to a decision by the US Food and Drug Administration (FDA).",
  "authors": [
    {
      "affiliations": [
        "Belfast"
      ],
      "name": "Chris Baraniuk"
    }
  ],
  "title": "Alzheimer’s drug lecanemab: FDA approves easier initial use, with “huge implications” for UK",
  "uid": "358148fc-7f9f-5f33-b5ca-0a1e78daf67a"
}